The Myth of ‘Build First, Worry Later’: Why Early Reimbursement Strategy is the Key to MedTech Survival
Published on: 03/08/2024
Why U.S. reimbursement strategy should begin long before FDA approval if you want to survive.
AIAI/MLReimbursement StrategyPayerPayer EngagementProduct DevelopmentHealthcare StakeholdersClinical UtilityEvidence
What Do Payers Mean by “Clinical Utility”?
Published on: 01/06/2024
“Clinical utility” is one of the most misunderstood payer terms. This article explains what U.S. payers expect and how to prepare.
AIArtificial IntelligenceMachine LanguageMLClinical UtilityEvidenceAI/MLInterventionPayersRegulatory ApprovalFDAFood and Drug Administration
